Treatment of Tinnitus With Olanzapine (NCT07190482) | Clinical Trial Compass
CompletedPhase 1
Treatment of Tinnitus With Olanzapine
Brazil50 participantsStarted 2023-10-01
Plain-language summary
This research aims to evaluate the effects of the drug olanzapine on the discomfort caused by tinnitus according to each patient's personality traits. Olanzapine is a drug used as an antipsychotic whose mechanism of action makes it potentially useful for the treatment of tinnitus.
Who can participate
Age range
18 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjective, non-pulsatile tinnitus of at least 6 months' duration
* Stable tinnitus symptoms over the past 3 months
* Willingness to participate and provide informed consent
* Age between 18 and 70 years
Exclusion Criteria:
* Active psychiatric disorders requiring pharmacological treatment
* History of psychotic illness or bipolar disorder
* Current use of antipsychotics, antidepressants, or anticonvulsants
* Severe hearing loss (threshold ≥ 80 dB in both ears)
* Substance use disorders
* Pregnancy or breastfeeding
* Known hypersensitivity to olanzapine
* Significant medical conditions (e.g., uncontrolled diabetes, hepatic impairment)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Evaluate the efficacy of olanzapine in reducing tinnitus symptoms in a randomized placebo-controlled crossover trial
Timeframe: From enrollment to the end of treatment at 12 weeks